Abstract
<p indent="0mm">Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is becoming a global pandemic. This deadly disease leads to multi-organ damage, including the respiratory, gastrointestinal and nervous systems. Organoids contain the cell types, and can partially retain the structure and function of the original tissues. Therefore, organoids have been widely applied into SARS-CoV-2 research as a new type of model. The organoid model can be used to faithfully mimic the infection process and clinical pathology of SARS-CoV-2, and should be a great platform for antiviral drug discovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
